BeOne Medicines Ltd. (ONC) EBIT

Annual EBIT:

-$568.20M+$639.54M(+52.95%)
December 31, 2024

Summary

  • As of today, ONC annual earnings before interest & taxes is -$568.20 million, with the most recent change of +$639.54 million (+52.95%) on December 31, 2024.
  • During the last 3 years, ONC annual EBIT has risen by +$870.54 million (+60.51%).
  • ONC annual EBIT is now -11889.85% below its all-time high of -$4.74 million, reached on December 1, 2013.

Performance

ONC EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

Quarterly EBIT:

$87.89M+$76.78M(+691.61%)
June 30, 2025

Summary

  • As of today, ONC quarterly earnings before interest & taxes is $87.89 million, with the most recent change of +$76.78 million (+691.61%) on June 30, 2025.
  • Over the past year, ONC quarterly EBIT has increased by +$195.05 million (+182.01%).
  • ONC quarterly EBIT is now -23.52% below its all-time high of $114.91 million, reached on September 1, 2017.

Performance

ONC Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

TTM EBIT:

-$100.70M+$195.05M(+65.95%)
June 30, 2025

Summary

  • As of today, ONC TTM earnings before interest & taxes is -$100.70 million, with the most recent change of +$195.05 million (+65.95%) on June 30, 2025.
  • Over the past year, ONC TTM EBIT has increased by +$785.57 million (+88.64%).
  • ONC TTM EBIT is now -1113.14% below its all-time high of -$8.30 million, reached on September 1, 2014.

Performance

ONC TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ONC EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+53.0%+182.0%+88.6%
3Y3 Years+60.5%+120.0%+94.8%
5Y5 Years+40.8%+124.5%+93.5%

ONC EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+68.3%at high+118.8%at high+94.7%
5Y5-Yearat high+68.3%at high+115.4%at high+94.8%
All-TimeAll-Time>-9999.0%+68.3%-23.5%+115.4%-1113.1%+94.8%

ONC EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$87.89M(+691.6%)
-$100.70M(+65.9%)
Mar 2025
-
$11.10M(+114.0%)
-$295.75M(+47.9%)
Dec 2024
-$568.20M(+53.0%)
-$79.42M(+34.0%)
-$568.20M(+34.9%)
Sep 2024
-
-$120.27M(-12.2%)
-$872.57M(+1.5%)
Jun 2024
-
-$107.16M(+59.0%)
-$886.27M(+19.3%)
Mar 2024
-
-$261.35M(+31.9%)
-$1.10B(+9.1%)
Dec 2023
-$1.21B(+32.5%)
-$383.80M(-186.5%)
-$1.21B(+6.6%)
Sep 2023
-
-$133.97M(+58.0%)
-$1.29B(+19.1%)
Jun 2023
-
-$318.71M(+14.2%)
-$1.60B(+7.0%)
Mar 2023
-
-$371.26M(+20.8%)
-$1.72B(+4.0%)
Dec 2022
-$1.79B(-24.4%)
-
-
Dec 2022
-
-$468.62M(-6.9%)
-$1.79B(+5.4%)
Sep 2022
-
-$438.36M(+0.2%)
-$1.89B(+1.3%)
Jun 2022
-
-$439.40M(+0.9%)
-$1.92B(+1.8%)
Mar 2022
-
-$443.29M(+22.5%)
-$1.95B(-35.7%)
Dec 2021
-$1.44B(+13.2%)
-$571.74M(-23.7%)
-$1.44B(-6.4%)
Sep 2021
-
-$462.32M(+2.6%)
-$1.35B(-1.7%)
Jun 2021
-
-$474.84M(-776.7%)
-$1.33B(-9.6%)
Mar 2021
-
$70.17M(+114.5%)
-$1.21B(+26.8%)
Dec 2020
-$1.66B(-72.7%)
-$484.91M(-10.2%)
-$1.66B(-6.2%)
Sep 2020
-
-$440.14M(-22.6%)
-$1.56B(-8.9%)
Jun 2020
-
-$358.88M(+4.0%)
-$1.43B(-23.5%)
Mar 2020
-
-$373.76M(+3.7%)
-$1.16B(-20.8%)
DateAnnualQuarterlyTTM
Dec 2019
-$959.89M(-36.0%)
-$388.04M(-24.3%)
-$959.89M(-12.6%)
Sep 2019
-
-$312.27M(-263.8%)
-$852.66M(-23.3%)
Jun 2019
-
-$85.83M(+50.6%)
-$691.50M(+10.0%)
Mar 2019
-
-$173.75M(+38.1%)
-$768.72M(-8.9%)
Dec 2018
-$705.77M(-616.8%)
-$280.81M(-85.8%)
-$705.77M(-33.5%)
Sep 2018
-
-$151.10M(+7.3%)
-$528.76M(-101.2%)
Jun 2018
-
-$163.05M(-47.1%)
-$262.75M(-66.6%)
Mar 2018
-
-$110.81M(-6.8%)
-$157.72M(-60.2%)
Dec 2017
-$98.46M(+15.9%)
-$103.80M(-190.3%)
-$98.46M(-208.4%)
Sep 2017
-
$114.91M(+298.0%)
-$31.93M(+82.4%)
Jun 2017
-
-$58.02M(-12.6%)
-$181.66M(-22.5%)
Mar 2017
-
-$51.54M(-38.3%)
-$148.27M(-26.7%)
Dec 2016
-$117.06M(-106.3%)
-$37.27M(-7.0%)
-$117.06M(-8.9%)
Sep 2016
-
-$34.83M(-41.4%)
-$107.52M(-24.5%)
Jun 2016
-
-$24.63M(-21.1%)
-$86.39M(-28.7%)
Mar 2016
-
-$20.33M(+26.7%)
-$67.13M(-18.3%)
Dec 2015
-$56.74M(-260.1%)
-$27.73M(-102.4%)
-$56.74M(-70.9%)
Sep 2015
-
-$13.70M(-155.2%)
-$33.20M(-19.4%)
Jun 2015
-
-$5.37M(+46.0%)
-$27.80M(-23.9%)
Mar 2015
-
-$9.95M(-137.5%)
-$22.43M(-79.6%)
Dec 2014
-$15.76M(-232.5%)
-$4.19M(+49.5%)
-$12.49M(-50.5%)
Sep 2014
-
-$8.30M
-$8.30M
Dec 2013
-$4.74M
-
-

FAQ

  • What is BeOne Medicines Ltd. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for BeOne Medicines Ltd.?
  • What is BeOne Medicines Ltd. annual EBIT year-on-year change?
  • What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?
  • What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?
  • What is BeOne Medicines Ltd. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for BeOne Medicines Ltd.?
  • What is BeOne Medicines Ltd. TTM EBIT year-on-year change?

What is BeOne Medicines Ltd. annual earnings before interest & taxes?

The current annual EBIT of ONC is -$568.20M

What is the all-time high annual EBIT for BeOne Medicines Ltd.?

BeOne Medicines Ltd. all-time high annual earnings before interest & taxes is -$4.74M

What is BeOne Medicines Ltd. annual EBIT year-on-year change?

Over the past year, ONC annual earnings before interest & taxes has changed by +$639.54M (+52.95%)

What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?

The current quarterly EBIT of ONC is $87.89M

What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?

BeOne Medicines Ltd. all-time high quarterly earnings before interest & taxes is $114.91M

What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?

Over the past year, ONC quarterly earnings before interest & taxes has changed by +$195.05M (+182.01%)

What is BeOne Medicines Ltd. TTM earnings before interest & taxes?

The current TTM EBIT of ONC is -$100.70M

What is the all-time high TTM EBIT for BeOne Medicines Ltd.?

BeOne Medicines Ltd. all-time high TTM earnings before interest & taxes is -$8.30M

What is BeOne Medicines Ltd. TTM EBIT year-on-year change?

Over the past year, ONC TTM earnings before interest & taxes has changed by +$785.57M (+88.64%)
On this page